Sleep

More than 1 in 4 patients with COVID-19 admitted to the hospital during the first wave of the pandemic in Finland were found to have obstructive sleep apnea, signaling a potential at-risk population.

Results from a phase 3 study of Xywav in adult patients with idiopathic hypersomnia exhibited its potential to address this unmet medical need.

Age, sex, and body mass index typically drive the development of obstructive sleep apnea, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, medical director, Sleep-Wake Center, University of Utah.

Experts spotlighted sex- and gender-specific changes in normal sleep and sleep disturbance, as well as attributable risk factors, during a session at the CHEST 2020 annual meeting.

In collaboration with the American Heart Association, Jazz Pharmaceuticals will provide a wide variety of sleep health educational content, including scientific research, reading materials for both patients and practitioners, and podcasts from experts in the field speaking to the importance of sleep on cardiovascular health.

Amid the coronavirus disease 2019 pandemic, patients with narcolepsy reported changes in bedtime and waking schedules, as well as an increase in adverse symptoms such as cataplexy and sleep paralysis.

Much of the population experiences disordered breathing at night, explained Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.

Adults with obstructive sleep apnea who are not adherent to continuous positive airway pressure (CPAP) therapy were found to be more likely to be hospitalized with influenza than those who used CPAP.

Aligned with recommendations published through the Choosing Wisely Campaign, pediatric sleep studies should be performed and interpreted according to pediatric, not adult, standards.

Solriamfetol was found to be efficacious and safe in the treatment of excessive daytime sleepiness in patients with narcolepsy and obstructive sleep apnea, according to study findings.

Inconsistent sleep was found to be significantly associated with inflammatory dysfunction, particularly in women, according to study findings.

An analysis finds Americans who are under the age of 25, shift workers, and living in urban areas are more likely to have sleep disorders.

CPAP treatment administered at night was found to lower daytime resting heart rates and reduce the risk of cardiovascular disease (CVD) in patients with prediabetes who have obstructive sleep apnea (OSA).

Telemedicine was indicated to provide complete and appropriate care for addressing pediatric sleep disorders such as insomnia and circadian rhythm disorders, whereas obstructive sleep apnea was better evaluated in office.

Former e-cigarette users were found to be more likely to report sleep deprivation compared with never users, according to study findings.

In addressing sleep-related challenges prior to and influenced by the coronavirus disease 2019 pandemic, researchers outline factors that contribute to optimal sleep hygiene among children and adolescents.

Health workers providing care on the front lines of the coronavirus disease 2019 (COVID-19) pandemic were found to develop more sleep disturbances and have worse quality of sleep compared with non-health care professionals.

In 2 separate articles, researchers review the relationship between obstructive sleep apnea (OSA) and cardiovascular disease, as well as the effects of continuous positive airway pressure treatment on level of physical activity in patients with these comorbid conditions.

Impaired sleep was found to contribute to more emotional reactions by study participants to stressful events the next day, with a comparative indifference to positive events also reported.

Researchers find that 32% of examined contact sport athletes who had developed chronic traumatic encephalopathy experienced sleep symptoms characteristic of rapid eye movement sleep behavior disorder, which only affect an estimated 1% of the general population.

Impaired sleep was associated with a higher rate of future beta amyloid accumulation, a potential catalyst of Alzheimer disease onset, according to study findings.

In findings from a novel global atlas study published today, 19 risk factors were identified to increase risk of developing type 2 diabetes, with insomnia identified as a risk factor for the first time.

For patients with insomnia amid the COVID-19 pandemic, certain nightly habits can promote sleep hygiene; in addition, lemborexant has emerged as a novel indication if drug intervention is needed.

Narcolepsy, along with several other conditions are examined as potential risk factors for coronavirus disease 2019 susceptibility and adverse outcomes.

Data to be presented at SLEEP 2020 showed Eisai Inc's lemborexant (DAYVIGO) had statistically significant long-term efficacy and safety compared with placebo on sleep maintenance and onset in patients with insomnia disorder, said Margaret Moline, PhD.